Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03936387 · ClinicalTrials.gov registry record · Phase 3

Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study

A Phase 3 study of Pain, Postoperative, sponsored by Boston Children's Hospital.

Completed
Registry status
Phase 3
Development phase
10
Enrollment target
1
Study location

NCT03936387: Completed Phase 3 study of Pain, Postoperative, sponsored by Boston Children's Hospital.

NCT03936387 is a Phase 3 study of Pain, Postoperative that has completed, run by Boston Children's Hospital. The registered enrollment target is 10 participants, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03936387, a Phase 3 study of Pain, Postoperative, has completed, sponsored by Boston Children's Hospital.

COMPLETED
Registry status
Phase 3
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Overall Aim: To evaluate the feasibility and potential benefits of investigating bilateral continuous erector spinae blocks (BESB) for postoperative pain management in a small cohort of children undergoing surgical sternotomy prior to planning an appropriately powered, randomized, controlled trial of the same. Hypothesis: The investigators' primary hypothesis is that utilizing bilateral erector spinae blocks for post-sternotomy pain is a feasible intervention for consideration in a larger trial by demonstrating a 75% or greater successful intervention completion rate without any major adverse outcomes.

Primary Outcome

For this study, 'feasibility' will be defined primarily as a successful intervention completion rate of 75% or greater of all subjects with no major adverse outcomes.

Conditions Studied

Interventions

  • DRUG Ropivacaine

Study Locations (1)

Massachusetts

  • Boston Children"S Hospital - Boston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-07-01
Est. Completion 2019-09-12
Phase Phase 3
Boston Children's Hospital

462 total trials

What the finished NCT03936387 record still lists

NCT03936387 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 273-participant average among 113 other Pain, Postoperative trials with a reported enrollment target (96% lower).

The record links to 1 condition, with Pain, Postoperative appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine is the first listed.

NCT03936387 reports a single indexed study location in Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03936387 about?

NCT03936387 is a clinical study titled "Bilateral Continuous Erector Spinae Blocks for Post-Sternotomy Pain Management: A Pilot Study". Overall Aim: To evaluate the feasibility and potential benefits of investigating bilateral continuous erector spinae blocks (BESB) for postoperative pain management in a small cohort of children undergoing surgical sternotomy prior to planning an appropriately powered, randomized, controlled trial o...

What is the current status of trial NCT03936387?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 10 participants. The study started on 2019-07-01. Estimated completion is 2019-09-12.

What conditions does trial NCT03936387 study?

This clinical trial studies the following conditions: Pain, Postoperative.

What interventions are being tested in trial NCT03936387?

The interventions under investigation include: Ropivacaine (DRUG).

Who is sponsoring clinical trial NCT03936387?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03936387 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03936387's enrollment target sits among peer trials

10 112th of 113 the lowest of 113 other Pain, Postoperative trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain, Postoperative trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03936387, the US trial registry maintained by the National Library of Medicine. NCT03936387 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.